1. Home
  2. FFWM vs IVA Comparison

FFWM vs IVA Comparison

Compare FFWM & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFWM
  • IVA
  • Stock Information
  • Founded
  • FFWM 1990
  • IVA 2011
  • Country
  • FFWM United States
  • IVA France
  • Employees
  • FFWM N/A
  • IVA N/A
  • Industry
  • FFWM Major Banks
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFWM Finance
  • IVA Health Care
  • Exchange
  • FFWM Nasdaq
  • IVA Nasdaq
  • Market Cap
  • FFWM 406.2M
  • IVA 359.6M
  • IPO Year
  • FFWM 2014
  • IVA 2020
  • Fundamental
  • Price
  • FFWM $5.95
  • IVA $6.19
  • Analyst Decision
  • FFWM Buy
  • IVA Strong Buy
  • Analyst Count
  • FFWM 2
  • IVA 5
  • Target Price
  • FFWM $6.25
  • IVA $13.60
  • AVG Volume (30 Days)
  • FFWM 697.6K
  • IVA 56.9K
  • Earning Date
  • FFWM 10-28-2025
  • IVA 09-24-2025
  • Dividend Yield
  • FFWM N/A
  • IVA N/A
  • EPS Growth
  • FFWM N/A
  • IVA N/A
  • EPS
  • FFWM N/A
  • IVA N/A
  • Revenue
  • FFWM $104,325,000.00
  • IVA $14,591,573.00
  • Revenue This Year
  • FFWM $164.53
  • IVA $80.35
  • Revenue Next Year
  • FFWM $9.97
  • IVA N/A
  • P/E Ratio
  • FFWM N/A
  • IVA N/A
  • Revenue Growth
  • FFWM N/A
  • IVA N/A
  • 52 Week Low
  • FFWM $4.42
  • IVA $1.53
  • 52 Week High
  • FFWM $8.52
  • IVA $6.50
  • Technical
  • Relative Strength Index (RSI)
  • FFWM 68.44
  • IVA 78.97
  • Support Level
  • FFWM $5.83
  • IVA $4.53
  • Resistance Level
  • FFWM $6.00
  • IVA $6.50
  • Average True Range (ATR)
  • FFWM 0.20
  • IVA 0.39
  • MACD
  • FFWM 0.07
  • IVA 0.20
  • Stochastic Oscillator
  • FFWM 95.41
  • IVA 89.53

About FFWM First Foundation Inc.

First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: